– USA, CA – CooperCompanies (NYSE: COO) today announced the election of Dr. Maria Rivas to its Board as an independent director, effective July 1, 2021.
“We are pleased to welcome Maria to our Board of Directors,” said CEO, Al White. “Maria brings a very valuable perspective with her background in fertility, medical affairs, product development, and global regulatory. We look forward to her advice and contributions as CooperCompanies continues to grow.”
About Dr. Maria Rivas
Dr. Maria Rivas currently serves as Chief Medical Officer and SVP for the healthcare business of Merck KGaA, Darmstadt, Germany which operates as EMD Serono in the US and Canada where she leads the Global Pharmacovigilance, Medical Affairs, and Evidence and Value Development teams in over 90 countries.
Before that, Dr. Rivas served as SVP, Global Medical Affairs at Merck & Co, as VP, Global Medical Affairs at Abbvie, as VP, Oncology, General Medicine and Diagnostic Imaging Medical Affairs at Bayer Healthcare, and in various roles at Eli Lilly including Head of US Women’s Health Medical Affairs.
Before joining Eli Lilly, Dr. Rivas was in private practice as an endocrinologist in Puerto Rico.
Born in Cuba, Dr. Rivas grew up in Puerto Rico and still has many families, friends, and professional connections there. In 2020, she was named among the Top 100 Most Influential Latinas by Latino Leaders Magazine.
About CooperCompanies
CooperCompanies is a global medical device company publicly traded on the NYSE. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies, and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
For more information: https://www.coopercos.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
